Traditional Chinese medicine preparation for treating mammary gland hyperplasia

Abstract

The invention relates to the technical field of pharmaceutical engineering, in particular to a traditional Chinese medicine preparation for treating hyperplasia of mammary glands. The pharmaceutical composition is prepared from radix bupleuri, radix paeoniae rubra, radix salviae miltiorrhizae, radix curcumae, spica prunellae, rhizoma cyperi, pericarpium citri reticulatae viride, murraya paniculata, radix angelicae sinensis, impatiens balsamina, livistona chinensis benth, herba ecliptae, lysimachia christinae hance, glechoma longituba and jasminum grandiflorum. Based on the principle of combining disease differentiation and syndrome differentiation of traditional Chinese medicine treatment of hyperplasia of mammary glands, the pharmaceutical composition treats both symptoms and root causes and treats both deficiency and excess, natural botanical drugs capable of soothing liver and regulating qi, softening hardness to dissipate stagnation, regulating Chong and Ren meridians and promoting blood circulation to arrest pain are screened out, and the pharmaceutical composition is precise and appropriate in drug combination, exact in curative effect, stable and low in cost. Through observation from the long-term and short-term clinical application process, no adverse reaction is generated.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical engineering, in particular to a traditional Chinese medicine composition for treating mammary gland hyperplasia. Background technique [0002] Hyperplasia of mammary glands has many names clinically, such as breast disease, fibrocystic disease of the breast, mammary gland disease, breast lobular hyperplasia, etc. The World Health Organization recommends that it be called mammary gland dysplasia, and most scholars in my country still use mammary gland hyperplasia. With the continuous improvement of living standards, the incidence of the disease is on the rise. Most scholars believe that the disease is related to the disorder of the hypothalamus-pituitary-ovary-mammary gland endocrine axis, and is the result of a variety of endocrine hormone disorders. Among them, the imbalance of estrogen / progesterone ratio leads to excessive hyperplasia and incomplete involution of breast parenchyma stimula...

AI Technical Summary

Problems solved by technology

However, this disease has the characteristics of periodicity and recurrent attacks. The above-mentioned western medicines have large side effects and cannot be taken for a long time.

[0005] At present, Chinese patent medicines for treating breast diseases mainly include Rujiling Granules, Rukuaixiao Tablets, Ruhe Sanjie Granules, Xiaojin Pills, Rukang Capsules, etc. Most of the above Chinese patent medicines for breast hyperplasia are for liver depression and Qi stagnation The resulting breast lumps and breast pain are not ideal for other types of breast hyperplasia